The development of an individualized digital memory book for Alzheimer's Disease patient: A case study

Author(s):  
Anis Hasliza Abu Hashim ◽  
Annas Najhan Ismail ◽  
Riaza Mohd Rias ◽  
Azlinah Mohamed
2017 ◽  
Vol 14 (4) ◽  
pp. 521 ◽  
Author(s):  
Yoo Hyun Um ◽  
Woo Hee Choi ◽  
Won Sang Jung ◽  
Young Ha Park ◽  
Chang-Uk Lee ◽  
...  

2020 ◽  
Vol 21 (5) ◽  
pp. 185-187
Author(s):  
Nozomu Uchida ◽  
Mayumi Ishida ◽  
Izumi Sato ◽  
Takao Takahashi ◽  
Daisuke Furuya ◽  
...  

2020 ◽  
Vol 5 (3) ◽  
pp. 97-115
Author(s):  
Karolina Krajewska ◽  

Introduction. Alzheimer's disease (AD – Alzheimer Disease) is an incurable neurodegenerative disease. The main source of memory discomfort is destruc-tion. With age, irresistibly falling ill with it. Risk factors for the development of Alzheimer's disease are primarily: diabetes, female gender, hypertension and the lack of a control field. It is estimated that in Poland Alzheimer's disease affects about 200,000 people. According to statistics, 60% of all forms of de-mentia are AD. Aim of the study. The aim of the study is to present the activities that should be performed by a nurse caring for a patient with diagnosed Alzheimer's dis-ease. Case study. A 75-year-old patient admitted to the internal medicine ward, she has communication, content swallowing and spatial orientation disorders. It requires constant assistance in the performance of everyday activities. He complains of urinary and faecal incontinence. Conclusion. Thanks to the holistic approach to the patient, it is possible to ensure her correctness and the approach of the patient and her family.


Author(s):  
André P. Smith ◽  
B. Lynn Beattie

Background:Informing patients and families about the diagnosis of Alzheimer’s disease (AD) is a complex ethical and practical issue. This qualitative study explores the psychosocial impact of disclosing a diagnosis of AD on patients and family members.Methods:This study identified 14 patients and their accompanying family members undergoing a multidisciplinary assessment for dementia at an outpatient clinic for AD and related disorders. Of the group, three patients had probable AD and five had possible AD as per NINCDS-ADRDAcriteria. Six patients were not demented as per DSM IIIR criteria. Disclosure of diagnosis occurred, in a family conference, within six to eight weeks of the assessment. Data collection methods included observation of the assessment and the family conference as well as in-depth home interviews with family members and with each patient whenever feasible. The interviews were transcribed verbatim and coded for recurrent themes.Results:A total of 40 individuals across 14 families participated in this study. Only two families chose not to have the patient attend the family conference. The disclosure of a diagnosis of probable AD brought on an experience of relief in three families, marking the end of a lengthy period of confusion about the nature of memory problems. Patients diagnosed with possible AD and their families interpreted how indicative the diagnosis was of the presence of the disease with varying degrees of certainty depending on pre-assessment beliefs about the cause of memory problems. In the group diagnosed as not demented, four patients had complaints of forgetfulness likely related to minor depression. The disclosure of a diagnosis of no dementia did not produce the anticipated relief. Two patients continued to believe their memory problems were caused by the early onset of AD or some other “organic” problem.Interpretation:This study reveals that disclosure of the diagnosis of AD to patients and family members is generally beneficial but that there are variations in the understanding of the diagnostic information, particularly in instances where the assessment results are ambiguous.


2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Daniel M Gilden ◽  
Joanna M Kubisiak ◽  
Kristin Kahle-Wrobleski ◽  
Daniel E Ball ◽  
Lee Bowman

2018 ◽  
Vol 96 (10) ◽  
pp. 1061-1079 ◽  
Author(s):  
Carlos Pascual-Caro ◽  
Maria Berrocal ◽  
Aida M. Lopez-Guerrero ◽  
Alberto Alvarez-Barrientos ◽  
Eulalia Pozo-Guisado ◽  
...  

Abstract STIM1 is an endoplasmic reticulum protein with a role in Ca2+ mobilization and signaling. As a sensor of intraluminal Ca2+ levels, STIM1 modulates plasma membrane Ca2+ channels to regulate Ca2+ entry. In neuroblastoma SH-SY5Y cells and in familial Alzheimer’s disease patient skin fibroblasts, STIM1 is cleaved at the transmembrane domain by the presenilin-1-associated γ-secretase, leading to dysregulation of Ca2+ homeostasis. In this report, we investigated expression levels of STIM1 in brain tissues (medium frontal gyrus) of pathologically confirmed Alzheimer’s disease patients, and observed that STIM1 protein expression level decreased with the progression of neurodegeneration. To study the role of STIM1 in neurodegeneration, a strategy was designed to knock-out the expression of STIM1 gene in the SH-SY5Y neuroblastoma cell line by CRISPR/Cas9-mediated genome editing, as an in vitro model to examine the phenotype of STIM1-deficient neuronal cells. It was proved that, while STIM1 is not required for the differentiation of SH-SY5Y cells, it is absolutely essential for cell survival in differentiating cells. Differentiated STIM1-KO cells showed a significant decrease of mitochondrial respiratory chain complex I activity, mitochondrial inner membrane depolarization, reduced mitochondrial free Ca2+ concentration, and higher levels of senescence as compared with wild-type cells. In parallel, STIM1-KO cells showed a potentiated Ca2+ entry in response to depolarization, which was sensitive to nifedipine, pointing to L-type voltage-operated Ca2+ channels as mediators of the upregulated Ca2+ entry. The stable knocking-down of CACNA1C transcripts restored mitochondrial function, increased mitochondrial Ca2+ levels, and dropped senescence to basal levels, demonstrating the essential role of the upregulation of voltage-operated Ca2+ entry through Cav1.2 channels in STIM1-deficient SH-SY5Y cell death. Key messages STIM1 protein expression decreases with the progression of neurodegeneration in Alzheimer’s disease. STIM1 is essential for cell viability in differentiated SH-SY5Y cells. STIM1 deficiency triggers voltage-regulated Ca2+ entry-dependent cell death. Mitochondrial dysfunction and senescence are features of STIM1-deficient differentiated cells.


Author(s):  
X. Zhu ◽  
G. Casadesus ◽  
K. M. Webber ◽  
C. S. Atwood ◽  
R. L. Bowen ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Andrew P. Owens ◽  
Chris Hinds ◽  
Nikolay V. Manyakov ◽  
Thanos G. Stavropoulos ◽  
Grace Lavelle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document